Thursday, June 18, 2026
🇺🇸 FDA

Medical condition

Brain Metastases

Brain Metastases is a medical condition tracked by NovaPharmaNews across 2 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.

Associated drugs & therapies

Latest Brain Metastases news

NCCN Adds Nuvation Bio's Taletrectinib (IBTROZI) to Cancer Treatment Guidelines for ROS1-Positive NSCLC with Brain Metastases
NewsApr 28, 2026

NCCN Adds Nuvation Bio's Taletrectinib (IBTROZI) to Cancer Treatment Guidelines for ROS1-Positive NSCLC with Brain Metastases

NCCN includes Nuvation Bio's taletrectinib as recommended treatment option for ROS1-positive non-small cell lung cancer patients with brain metastases.

Dr. Priya Nandakumar

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.